Not exact matches
«Several major advances in recent years have been good news for
multiple myeloma patients, but those new drugs only
target terminally differentiated cancer cells and thus can only reduce the bulk of the
tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego Health.
The investigators utilized a
targeting method called RNA interference (RNAi) which, when delivered via these natural nanoparticles or exosomes, zero in on mutant KRAS in pancreas cancer cells, impacting
tumor burden and survival in
multiple pancreas cancer models.
«Thanks to a deeper understanding of cancer biology, we have a potential new
targeted therapy for
multiple myeloma, and can better tailor treatment for kids with Wilms
tumor.
Based on their results, Lu and her colleagues argue that the best strategy in such cases might be to use drug combinations that
target multiple, parallel pathways involved in
tumor development and maintenance.
One miRNA can
target multiple genes, but their expression is often hijacked by cancer cells and disrupts
multiple cancer - causing or
tumor - suppressing pathways,» says Shuk - Mei Ho, PhD, director of the CCC and Jacob G. Schmidlapp Chair of Environmental Health and professor at the University of Cincinnati (UC) College of Medicine.
The Cancer Vaccine Collaborative is working on treatments that
target multiple cancer antigens, which should trigger a more aggressive immune response and increase the odds of defeating
tumors.
If metastatic cancers are most often made up of cells with different genetic drivers, perhaps researchers should be
targeting the primary
tumor with
multiple drugs to contain the cancer.
However, resistance almost always develops because
tumors harbor
multiple genomic defects capable of driving the disease after a
targeted drug knocks down one driver.
MRI technology was used to identify and locate a probably
tumor (outlined in yellow) during a
targeted prostate biopsy for a patient who had previously had
multiple negative biopsies but had persistently high PSA levels.
A proteomic analysis of the
tumors also identified
multiple protein
targets that have the potential to respond to drugs.
Whereas earlier, unsuccessful cancer vaccines usually
targeted a single distinctive cancer protein shared among patients, these new ones contain
multiple mutated proteins, or «neoantigens,» that are specific to an individual patient's
tumor.
However, about 10 percent of them are common across
multiple cancers, suggesting that a relatively small number of therapies
targeting these core dependencies might each hold promise for combatting several
tumors.
«Our results are the first to provide insight into ways of
targeting multiple brain metastatic deposits with stem - cell - loaded oncolytic viruses that specifically kill dividing
tumor cells.»
In their search for novel,
tumor - specific therapies that could
target multiple brain metastases without damaging adjacent tissues, the research team first developed a mouse model that more closely mimics what is seen in patients.
Antibiotics that
target mitochondria effectively eradicate cancer stem cells, across
multiple tumor types: treating cancer like an infectious disease.
MicroRNA 218 acts as a
tumor suppressor by
targeting multiple cancer phenotype - associated genes in medulloblastoma.
These GEMM - ESCs, with often
multiple modified alleles, form the basis for further genetic engineering either by Flp - recombinase mediated integration, gene
targeting or Crispr / Cas9 to allow for the evaluation of altered
target gene expression in a spontaneous
tumor model.
My studies of cancer genomes have led to characterization of
multiple pediatric and adult
tumor types, to development of methods that identify and characterize changes in genomic heterogeneity, to defining acquired resistance mechanisms to
targeted therapies and to designing novel, personalized vaccines for individual patients.
«We have created a potentially much less expensive approach to making a therapeutic cancer vaccine that, while
targeting a single
tumor antigen, generates an immune response against
multiple antigens.
In addition, because ZVex product candidates have the potential to carry the genetic material of different
tumor antigens, as well as immunostimulatory molecules, we can design them to
target multiple types of cancers.
«We're using the whole
tumor cell, and that allows us to stimulate a response that's broad, that's against
multiple targets, and that's against
targets that are unique to that individual patient,» Avigan said.